Andres Felipe Pineda Torres What is ePRO, Electronic Patient-Reported Outcome? What is electronic patient-reported outcomes (ePRO)? ePRO stands for " Electronic Patient-Reported Outcomes. " It is a tool that allows patients to record electronically and submit their health outcom... Resources TrialPal Mar 21, 2024
Andres Felipe Pineda Torres Electronic Clinical Outcome Assessment (eCOA): What is and Who Uses it? Table of Contents The global eCOA market is poised for significant growth in the coming years. Grand View Research shows the market is expected to reach $20.5 billion by 2028. eCOA (electronic Clinica... Resources TrialPal Mar 14, 2024
Andres Felipe Pineda Torres Adherence Reporting in Vaccine Trials: [+98% Adherence Rates] Poor patient reporting adherence can prolong the trial duration by increasing the time required to gather complete and accurate data. This can extend the overall cost of the trial while burdening the ... Resources TrialPal Feb 16, 2024
Andres Felipe Pineda Torres Differences and similarities between an eCOA and ePRO Electronic Clinical Outcome Assessments (eCOA) and Electronic Patient Reported Outcomes (ePRO) are two types of electronic data collection methods. While they may seem similar, there are some differen... Resources TrialPal Jun 26, 2023
Andres Felipe Pineda Torres Rising Equity in Clinical Trials and Emerging Countries Through Tech An FDA 2020 report (1) has shown a 28% decrease in underrepresented populations in United States clinical trials compared to 2018. Moreover, the 2022 FDA guidance for the industry to improve underrepr... Resources Trial 360 TrialPal Apr 17, 2023
Andres Felipe Pineda Torres Seven ePRO/eCOA Capabilities to Better Conduct Clinical Studies in Latin America ePRO/eCOA Capabilities to better conduct Clinical Studies ePRO/eCOA tools have revolutionized the clinical research industry. The first concept was raised a decade ago, but the idea of integrations be... Resources TrialPal Nov 23, 2022
Andres Felipe Pineda Torres Efficient Clinical Trial of the Polio Vaccine Against the Second Wild Strain, Vital for Children in Africa An efficient clinical trial of the polio vaccine was critical for the emergency approval of the sponsor vaccine against the second wild strain. Then, solve the delicate health situation in Africa due ... PFS Resources Study Cases TrialPal Aug 16, 2022
Andres Felipe Pineda Torres How to achieve a 98% eDiary reporting compliance rate in older adults with TrialPal Cevaxin, a research Site located in Panama, used TrialPal to achieve an outstanding eDiary reporting compliance rate in a Phase I vaccine clinical trial with older adults. While developing clinical tr... Resources Study Cases TrialPal Jul 13, 2022
Andres Felipe Pineda Torres COVID-19 studies in healthcare workers - University of Mainz COVID-19 studies in healthcare workers in University of Mainz Integra IT had the opportunity to participate and contribute with its tools in observational COVID-19 studies conducted by the University ... Integration Resources Study Cases TrialPal Jul 5, 2022
Andres Felipe Pineda Torres Integra IT, part of the Fiocruz COVID-19 vaccine trial in Brazil Integra IT software solutions has been essential for developing the Fiocruz vaccine Phase 3 trial for SARS-CoV-2 in Brazil , achieving efficiency in data collection and organization. This project coll... Resources Study Cases TrialPal Jun 15, 2022
Andres Felipe Pineda Torres Integra IT, COVID19 Study in Peru Peru, a country of nearly 33 million people, was hit by the COVID-19 coronavirus pandemic mainly because the health system, like that of many other countries, was not prepared for a health challenge o... Resources Study Cases TrialPal Nov 15, 2021
![Adherence Reporting in Vaccine Trials: [+98% Adherence Rates]](/web/image/blog.post/936/author_avatar/Adherence%20Reporting%20in%20Vaccine%20Trials:%20%5B%2B98%25%20Adherence%20Rates%5D?unique=58ea1d4)
